NEW: FDA's Julie Tierney and Dr. Nicole Verdun to Speak at ASGCT's Policy Summit (Sept. 23-24). Register Now!
The ASGCT Catalyst Award recognizes an ASGCT member or team of professionals who have had an extraordinary impact on the translation of gene and cell therapies. The award is intended to highlight contributions in areas such as biomarker identification or endpoint development, manufacturing and scale-up, policy, or regulatory science, among others. Work in these areas are the advances that drive innovation and catalyze translation of cell and gene therapies to the clinic.
To be eligible, potential recipients must be nominated by two or more ASGCT members in good standing. The Nominating and Awards Committee will review nominations and make a recommendation to the Board of Directors, which retains responsibility for selecting the recipient.
The recipient(s) of the Catalyst Award will be announced in advance of the Annual Meeting. The recipient(s) will be recognized within a general session when they are presented with their award. Recipients will receive a plaque or trophy, complimentary registration, and an honorarium of $2,000.
Nominations for the 2024 Annual Meeting are open through Jan. 31, 2024. Please send your nominations to awards@asgct.org.
2023 Joy Cavagnaro, PhD
September 23-24, 2024 | Washington, D.C.
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico